Items where authors include "McMahon, K"

Article

Cragg, WJ orcid.org/0000-0002-1274-8521, McMahon, K, Oughton, JB orcid.org/0000-0002-2047-804X et al. (3 more authors) (2021) Correction to: Clinical trial recruiters’ experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK. Trials, 22 (1). 862. ISSN 1745-6215

Westbrook, JA, Wood, SL, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of pathology, 247 (3). pp. 381-391. ISSN 0022-3417

Collett, L, Howard, DR orcid.org/0000-0003-3333-9783, Munir, T et al. (11 more authors) (2017) Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials, 18. 387. ISSN 1745-6215

Oughton, JB orcid.org/0000-0002-2047-804X, Collett, L, Howard, DR orcid.org/0000-0003-3333-9783 et al. (8 more authors) (2017) GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial. Trials, 18. 353. ISSN 1745-6215

Abraham, S, Scarcia, M, Bagshaw, R et al. (15 more authors) (2015) A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nature Communications, 6. 7286. ISSN 2041-1723

Proceedings Paper

Grant, G, Gahlaut, R, Abraham, S et al. (9 more authors) (2015) The role of dock4 in cancer cell invasion and angiogenesis in breast cancer brain metastates. In: Neuro-Oncology. Meeting of the British-Neuro-Oncology-Society, 01-03 Jul 2015, Nottingham, UK. Oxford University Press , p. 10.